Ocular Therapeut (NQ: OCUL )
7.860
+0.010
(+0.13%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Jul 22, 2024
Add to My Watchlist
All News about Ocular Therapeut
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/mid-day_movers_image_42.jpg)
![](https://g.foolcdn.com/editorial/images/647878/investor-watching-stock-tank.jpg)
![](https://mms.businesswire.com/media/20211022005097/en/807582/5/OCUTX_Logo_RGB_1200x700_FINAL.jpg)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/biotech2.jpg)
The Week Ahead In Biotech (Aug. 8-14): Jazz Pharma FDA Decision, Earnings Deluge and IPOs In The Spotlight
August 08, 2021
Via Benzinga
Exposures
Product Safety
![](https://cdn2.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/price_targets_297.png?width=720)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/biotech_laboratory-g8113d1286_1920.jpg)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/yesterdays_movers_306.png)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/aapharma_2180.png)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2021/movers_image_2778.jpeg)
![](https://mms.businesswire.com/media/20211011005575/en/807582/5/OCUTX_Logo_RGB_1200x700_FINAL.jpg)
Via Business Wire
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/sites/all/themes/bz2/images/bz-icon.png)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/pill-1884777_1920_0_5_17.jpg)
![](https://mms.businesswire.com/media/20210928005387/en/807582/5/OCUTX_Logo_RGB_1200x700_FINAL.jpg)
![](https://mms.businesswire.com/media/20210922005315/en/807582/5/OCUTX_Logo_RGB_1200x700_FINAL.jpg)
Ocular Therapeutix™ Appoints Merilee Raines to Its Board of Directors
September 22, 2021
Via Business Wire
![](https://mms.businesswire.com/media/20210913005223/en/807582/5/OCUTX_Logo_RGB_1200x700_FINAL.jpg)
![](https://mms.businesswire.com/media/20210907005124/en/807582/5/OCUTX_Logo_RGB_1200x700_FINAL.jpg)
![](https://g.foolcdn.com/editorial/images/639551/eye-doctor-with-patient.jpg)
![](https://g.foolcdn.com/editorial/images/639580/life-science-pro-making-selection-getty.jpg)
![](https://mms.businesswire.com/media/20210810005316/en/807582/5/OCUTX_Logo_RGB_1200x700_FINAL.jpg)
![](https://mms.businesswire.com/media/20210809005723/en/807582/5/OCUTX_Logo_RGB_1200x700_FINAL.jpg)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/aapharma_1371.png)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/earnings_scheduled_1918.png)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/medicine-1309148_1920_361.jpg)
![](https://mms.businesswire.com/media/20210805005965/en/807582/5/OCUTX_Logo_RGB_1200x700_FINAL.jpg)
![](https://mms.businesswire.com/media/20210729005328/en/807582/5/OCUTX_Logo_RGB_1200x700_FINAL.jpg)
![](https://mms.businesswire.com/media/20210728005215/en/807582/5/OCUTX_Logo_RGB_1200x700_FINAL.jpg)
![](https://mms.businesswire.com/media/20210723005093/en/807582/5/OCUTX_Logo_RGB_1200x700_FINAL.jpg)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/medicine-1309148_1920_357.jpg)
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.